Average Co-Inventor Count = 6.22
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hoffmann-La Roche Inc. (35 from 4,948 patents)
2. Roche Glycart Ag (1 from 68 patents)
3. Prothena Biosciences Limited (1 from 58 patents)
4. F. Hoffmann-La Roche Ag (168 patents)
36 patents:
1. 12297263 - Humanized anti-Tau(PS422) antibodies and methods of use
2. 11866490 - Antibody that binds to VEGF and IL-1beta and methods of use
3. 11572404 - Humanized anti-Tau(pS422) antibodies and methods of use
4. 11273223 - Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttles
5. 11130804 - Antibody that binds to VEGF and IL-1beta and methods of use
6. 10822402 - Humanized anti-tau(pS422) antibodies and methods of use
7. 10806795 - Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttles
8. 10730938 - Bispecific antibodies and methods of use in ophthalmology
9. 10647761 - Anti-alpha-synuclein antibodies and methods of use
10. 10561737 - Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttles
11. 10562973 - Blood-brain barrier shuttles containing antibodies recognizing alpha-synuclein
12. 10465000 - Humanized anti-Tau(pS422) antibodies and methods of use
13. 10344085 - Anti-IL-1beta antibodies
14. 10316082 - Anti-alpha-synuclein antibodies and methods of use
15. 10087246 - Anti-PDGF-B antibodies and methods of use